Table 4.

Medications used on admission and during hospitalization

Drugs	Medications on admission				Medications during hospitalization
	All patients	AKI	Non-AKI	P value	All patients	AKI	Non-AKI	P value
RAAS inhibitors	33 of 701 (4.7)	0 of 36 (0.0)	33 of 665 (5.0)	0.334	41 of 701 (5.8)	0 of 36 (0.0)	41 of 665 (6.2)	0.242
Antibiotics	498 of 701 (71.0)	27 of 36 (75.0)	471 of 665 (70.8)	0.591	600 of 701 (85.6)	35 of 36 (97.2)	565 of 665 (85.0)	0.041
Antivirals	512 of 701 (73.0)	21 of 36 (58.3)	491 of 665 (73.8)	0.041	658 of 701 (93.9)	32 of 36 (88.9)	626 of 665 (94.1)	0.357
Umifenovir	343 of 701 (48.9)	14 of 36 (38.9)	329 of 665 (49.5)	0.216	475 of 701 (67.8)	17 of 36 (47.2)	458 of 665 (68.9)	0.007
Ganciclovir	24 of 701 (3.4)	0 of 36 (0.0)	24 of 665 (3.6)	0.491	27 of 701 (3.9)	0 of 36 (0.0)	27 of 665 (4.1)	0.430
Interferon	129 of 701 (18.4)	6 of 36 (16.7)	123 of 665 (18.5)	0.783	169 of 701 (24.1)	9 of 36 (25.0)	160 of 665 (24.1)	0.898
Lopinavir and ritonavir	74 of 701 (10.6)	2 of 36 (5.6)	72 of 665 (10.8)	0.469	196 of 701 (28.0)	4 of 36 (11.1)	192 of 665 (28.9)	0.021
Oseltamivir	39 of 701 (5.6)	1 of 36 (2.8)	38 of 665 (5.7)	0.707	79 of 701 (11.3)	1 of 36 (2.8)	78 of 665 (11.7)	0.166
Ribavirin	8 of 701 (1.1)	0 of 36 (0.0)	8 of 665 (1.2)	1.000	33 of 701 (4.7)	0 of 36 (0.0)	33 of 665 (5.0)	0.334
Antidiabetic	68 of 701 (9.7)	3 of 36 (8.3)	65 of 665 (9.8)	1.000	119 of 701 (17.0)	4 of 36 (11.1)	115 of 665 (17.3)	0.336
Diuretics	10 of 701 (1.4)	1 of 36 (2.8)	9 of 665 (1.4)	0.412	67 of 701 (9.6)	26 of 36 (72.2)	41 of 665 (6.2)	<0.001
Glucocorticoids	259 of 701 (36.9)	21 of 36 (58.3)	238 of 665 (35.8)	0.006	387 of 701 (55.2)	22 of 36 (61.1)	365 of 665 (54.9)	0.465

AKI, acute kidney injury; RAAS, renin-angiotensin-aldosterone system.

RAAS inhibitors include angiotensin-converting-enzyme inhibitor and angiotensin receptor blocker.